105 related articles for article (PubMed ID: 8201704)
1. Diabetes mellitus and experimental vein graft structure and function.
Davies MG; Kim JH; Klyachkin ML; Barber L; Dalen H; Svendsen E; Carson CC; Hagen PO
J Vasc Surg; 1994 Jun; 19(6):1031-43. PubMed ID: 8201704
[TBL] [Abstract][Full Text] [Related]
2. Time course of the regression of intimal hyperplasia in experimental vein grafts.
Davies MG; Fulton GJ; Svendsen E; Hagen PO
Cardiovasc Pathol; 1999; 8(3):161-8. PubMed ID: 10722239
[TBL] [Abstract][Full Text] [Related]
3. Lazaroid therapy (methylaminochroman: U83836E) reduces vein graft intimal hyperplasia.
Davies MG; Dalen H; Barber L; Svendsen E; Hagen PO
J Surg Res; 1996 Jun; 63(1):128-36. PubMed ID: 8661185
[TBL] [Abstract][Full Text] [Related]
4. Reduction of experimental vein graft intimal hyperplasia and preservation of nitric oxide-mediated relaxation by the nitric oxide precursor L-arginine.
Davies MG; Kim JH; Dalen H; Makhoul RG; Svendsen E; Hagen PO
Surgery; 1994 Sep; 116(3):557-68. PubMed ID: 8079186
[TBL] [Abstract][Full Text] [Related]
5. Controlling transplant vasculopathy in cryopreserved vein grafts with polyethylene glycol and glutathione during transport.
Davies MG; Huynh TT; Fulton GJ; Svendsen E; Brockbank FG; Hagen PO
Eur J Vasc Endovasc Surg; 1999 Jun; 17(6):493-500. PubMed ID: 10375485
[TBL] [Abstract][Full Text] [Related]
6. Oral monoterpene therapy (perillyl alcohol) reduces vein graft intimal hyperplasia.
Fulton GJ; Barber L; Svendsen E; Hagen PO; Davies MG
J Surg Res; 1997 Apr; 69(1):128-34. PubMed ID: 9202658
[TBL] [Abstract][Full Text] [Related]
7. Functional and histological differences in autogenous and allogenic vein grafts: two different vasculopathies?
Davies MG; Dalen H; Svendsen E; Hagen PO
J Surg Res; 1997 Apr; 69(1):14-22. PubMed ID: 9202641
[TBL] [Abstract][Full Text] [Related]
8. Antisense oligonucleotide to proto-oncogene c-myb inhibits the formation of intimal hyperplasia in experimental vein grafts.
Fulton GJ; Davies MG; Koch WJ; Dalen H; Svendsen E; Hagen PO
J Vasc Surg; 1997 Mar; 25(3):453-63. PubMed ID: 9081126
[TBL] [Abstract][Full Text] [Related]
9. The influence of the combined presence of diabetes mellitus and hypercholesterolaemia on the function and morphology of experimental vein grafts.
Davies MG; Dalen H; Kim JH; Barber L; Svendsen E; Hagen PO
Eur J Vasc Endovasc Surg; 1995 Aug; 10(2):142-55. PubMed ID: 7655965
[TBL] [Abstract][Full Text] [Related]
10. Early morphology of accelerated vein graft atheroma in experimental vein grafts.
Davies MG; Huynh TT; Fulton GJ; Barber L; Svendsen E; Hagen PO
Ann Vasc Surg; 1999 Jul; 13(4):378-85. PubMed ID: 10398734
[TBL] [Abstract][Full Text] [Related]
11. Local effects of nitric oxide supplementation and suppression in the development of intimal hyperplasia in experimental vein grafts.
Fulton GJ; Davies MG; Barber L; Gray JL; Svendsen E; Hagen PO
Eur J Vasc Endovasc Surg; 1998 Apr; 15(4):279-89. PubMed ID: 9610339
[TBL] [Abstract][Full Text] [Related]
12. Hypercholesterolemia and experimental vein grafts: accelerated development of intimal hyperplasia and an increase in abnormal vasomotor function.
Klyachkin ML; Davies MG; Svendsen E; Kim JH; Massey MF; Barber L; McCann RL; Hagen PO
J Surg Res; 1993 May; 54(5):451-68. PubMed ID: 8361171
[TBL] [Abstract][Full Text] [Related]
13. Suppression of intimal hyperplasia in experimental vein grafts by oral l-arginine supplementation and single ex vivo immersion in deferoxamine manganese.
Davis MG; Dalen H; Austerheim AM; Gulbrandsen TF; Svendsen E; Hagen PO
J Vasc Surg; 1996 Mar; 23(3):410-20. PubMed ID: 8601882
[TBL] [Abstract][Full Text] [Related]
14. Influence of perioperative catheter injury on the long-term vein graft function and morphology.
Davies MG; Dalen H; Svendsen E; Hagen PO
J Surg Res; 1996 Dec; 66(2):109-14. PubMed ID: 9024820
[TBL] [Abstract][Full Text] [Related]
15. Combination therapy of cholesterol reduction and L-arginine supplementation controls accelerated vein graft atheroma.
Davies MG; Fulton GJ; Huynh TT; Barber L; Svendsen E; Hagen PO
Ann Vasc Surg; 1999 Sep; 13(5):484-93. PubMed ID: 10466992
[TBL] [Abstract][Full Text] [Related]
16. Characterization of dopamine-mediated relaxation in experimental vein bypass grafts.
Davies MG; Huynh TT; Hagen PO
J Surg Res; 2000 Jul; 92(1):103-7. PubMed ID: 10864489
[TBL] [Abstract][Full Text] [Related]
17. VCAM-1 expression precedes macrophage infiltration into subendothelium of vein grafts interposed into carotid arteries in hypercholesterolemic rabbits--a potential role in vein graft atherosclerosis.
Hanyu M; Kume N; Ikeda T; Minami M; Kita T; Komeda M
Atherosclerosis; 2001 Oct; 158(2):313-9. PubMed ID: 11583709
[TBL] [Abstract][Full Text] [Related]
18. Local delivery of a tissue factor antibody reduces early leukocyte infiltration but fails to limit intimal hyperplasia in experimental vein grafts.
Annex BH; Davies MG; Fulton GJ; Huynh TT; Channon KM; Ezekowitz MD; Hagen PO
J Surg Res; 1998 Dec; 80(2):164-70. PubMed ID: 9878308
[TBL] [Abstract][Full Text] [Related]
19. Systemic hypertension and hypercholesterolemia in vein grafts: effects on the function and morphology of experimental vein grafts.
Davies MG; Kim JH; Barber L; Dalen H; Svendsen E; Hagen PO
J Surg Res; 1994 Jul; 57(1):106-21. PubMed ID: 8041125
[TBL] [Abstract][Full Text] [Related]
20. Influence of perioperative storage solutions on long-term vein graft function and morphology.
Davies MG; Hagen PO
Ann Vasc Surg; 1994 Mar; 8(2):150-7. PubMed ID: 8198948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
